Rituximab response in follicular lymphoma: contributions from KIR 2DS1 and HLA-C
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Rituximab response in follicular lymphoma: contributions from KIR 2DS1 and HLA-C ; volume:1 ; number:1 ; day:7 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Journal for ImmunoTherapy of Cancer ; 1, Heft 1 (7.11.2013), 1, 11.2013
- Urheber
-
Erbe, A K.
- Beteiligte Personen und Organisationen
-
Wang, Wei
Grzywacz, B.
Ranheim, E A.
Hank, J A.
Kim, K.
Carmichael, L.
Seo, S.
Mendonca, E A.
Song, Y.
Hong, F.
Gascoyne, R D.
Paietta, E.
Horning, S H.
Kahl, B.
Sondel, P M.
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-1-S1-P243
- URN
-
urn:nbn:de:1111-2016072652946
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Erbe, A K.
- Wang, Wei
- Grzywacz, B.
- Ranheim, E A.
- Hank, J A.
- Kim, K.
- Carmichael, L.
- Seo, S.
- Mendonca, E A.
- Song, Y.
- Hong, F.
- Gascoyne, R D.
- Paietta, E.
- Horning, S H.
- Kahl, B.
- Sondel, P M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
Follicular lymphoma
Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma
A rare face of follicular lymphoma: reverse variant of follicular lymphoma
Atypical burkitt's lymphoma transforming from follicular lymphoma
Follicular lymphoma of the duodenum
Follicular lymphoma of the duodenum
Follicular lymphoma and marginal zone lymphoma: how many diseases?
Constitutive AKT activation in follicular lymphoma
KIR and HLA-C genes in male infertility
Activating KIR/HLA complexes in classic Kaposi's Sarcoma
Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
Follicular lymphoma
Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma
A rare face of follicular lymphoma: reverse variant of follicular lymphoma
Atypical burkitt's lymphoma transforming from follicular lymphoma
Follicular lymphoma of the duodenum
Follicular lymphoma of the duodenum
Follicular lymphoma and marginal zone lymphoma: how many diseases?
Constitutive AKT activation in follicular lymphoma
KIR and HLA-C genes in male infertility
Activating KIR/HLA complexes in classic Kaposi's Sarcoma
Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
Follicular lymphoma
Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma
A rare face of follicular lymphoma: reverse variant of follicular lymphoma
Atypical burkitt's lymphoma transforming from follicular lymphoma
Follicular lymphoma of the duodenum
Follicular lymphoma of the duodenum
Follicular lymphoma and marginal zone lymphoma: how many diseases?
Constitutive AKT activation in follicular lymphoma
KIR and HLA-C genes in male infertility
Activating KIR/HLA complexes in classic Kaposi's Sarcoma